Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 20

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today reported…